ZA815128B - 9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives thereof - Google Patents

9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives thereof

Info

Publication number
ZA815128B
ZA815128B ZA815128A ZA815128A ZA815128B ZA 815128 B ZA815128 B ZA 815128B ZA 815128 A ZA815128 A ZA 815128A ZA 815128 A ZA815128 A ZA 815128A ZA 815128 B ZA815128 B ZA 815128B
Authority
ZA
South Africa
Prior art keywords
hydroxyoctahydrobenzo
quinolines
derivatives
amino
Prior art date
Application number
ZA815128A
Other languages
English (en)
Inventor
M Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA815128B publication Critical patent/ZA815128B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ZA815128A 1980-07-28 1981-07-27 9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives thereof ZA815128B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/173,207 US4309545A (en) 1980-07-28 1980-07-28 Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
ZA815128B true ZA815128B (en) 1982-07-28

Family

ID=22630983

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA815128A ZA815128B (en) 1980-07-28 1981-07-27 9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives thereof

Country Status (29)

Country Link
US (1) US4309545A (de)
EP (1) EP0045171B1 (de)
JP (1) JPS57112372A (de)
KR (1) KR850000273B1 (de)
AR (1) AR230988A1 (de)
AT (1) ATE11775T1 (de)
AU (1) AU525944B2 (de)
CA (1) CA1178274A (de)
CS (1) CS228515B2 (de)
DD (1) DD202012A5 (de)
DE (1) DE3168891D1 (de)
DK (1) DK334581A (de)
EG (1) EG15535A (de)
ES (1) ES504323A0 (de)
FI (1) FI812338L (de)
GR (1) GR75283B (de)
GT (1) GT198170557A (de)
HU (1) HU185133B (de)
IE (1) IE51426B1 (de)
IL (1) IL63423A0 (de)
IN (1) IN158867B (de)
NO (2) NO812557L (de)
NZ (1) NZ197856A (de)
PH (1) PH17281A (de)
PL (1) PL133928B1 (de)
PT (1) PT73440B (de)
SU (1) SU1217254A3 (de)
YU (1) YU185181A (de)
ZA (1) ZA815128B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4920221A (en) * 1982-03-16 1990-04-24 Pfizer Inc. Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
PT882021E (pt) * 1996-01-31 2003-07-31 Altana Pharma Ag Novas fenantridinas
CA2250569C (en) * 1996-03-26 2005-05-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel phenanthridines substituted in the 6 position
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
WO1999005112A1 (en) * 1997-07-25 1999-02-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted 6-alkylphenanthridines
CA2297911C (en) * 1997-07-25 2007-09-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted 6-phenylphenanthridines
US6274635B1 (en) 1999-03-22 2001-08-14 Immugen Pharmaceuticals Inc. Alkylated resorcinol derivatives for the treatment of immune diseases
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20060084021A1 (en) * 2004-09-10 2006-04-20 Kubicek Chris A Wick holder
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2003214226A1 (en) * 2002-03-18 2003-10-08 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
US7678829B2 (en) * 2004-05-25 2010-03-16 Qlt Inc. Oculoselective drugs and prodrugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839441A (en) * 1969-10-27 1974-10-01 Hoffmann La Roche Intermediates for partially hydrogenated phenanthridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
HU180917B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás 5, 6, 6a, 7-tetrahidro-benzo [c] kinolin-9(8H)-on-származékok előállítására
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4152450A (en) * 1978-02-17 1979-05-01 Eli Lilly And Company 9-Amino-dibenzopyrans

Also Published As

Publication number Publication date
IL63423A0 (en) 1981-10-30
AR230988A1 (es) 1984-08-31
EP0045171B1 (de) 1985-02-13
CA1178274A (en) 1984-11-20
EP0045171A2 (de) 1982-02-03
ATE11775T1 (de) 1985-02-15
GT198170557A (es) 1983-01-12
PL133928B1 (en) 1985-07-31
AU525944B2 (en) 1982-12-09
ES8301926A1 (es) 1982-12-16
IE51426B1 (en) 1986-12-24
PT73440A (en) 1981-08-01
YU185181A (en) 1983-12-31
NZ197856A (en) 1984-10-19
DD202012A5 (de) 1983-08-24
US4309545A (en) 1982-01-05
IE811686L (en) 1982-01-28
GR75283B (de) 1984-07-13
KR850000273B1 (ko) 1985-03-15
NO812557L (no) 1982-01-29
KR830006217A (ko) 1983-09-20
CS228515B2 (en) 1984-05-14
DK334581A (da) 1982-01-29
PL232331A1 (en) 1983-09-26
SU1217254A3 (ru) 1986-03-07
HU185133B (en) 1984-12-28
JPS57112372A (en) 1982-07-13
EP0045171A3 (en) 1982-04-28
ES504323A0 (es) 1982-12-16
AU7343481A (en) 1982-05-06
PH17281A (en) 1984-07-06
EG15535A (en) 1986-09-30
FI812338L (fi) 1982-01-29
IN158867B (de) 1987-02-07
NO854454L (no) 1985-01-29
DE3168891D1 (en) 1985-03-28
PT73440B (en) 1983-06-20

Similar Documents

Publication Publication Date Title
PT73995A (en) Thiadiazinone oxadiazinone and triazinone derivatives
GB2094789B (en) Carbostyril derivatives
DE3168891D1 (en) 9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives thereof
IL61930A0 (en) 25-hydroxy-26,26,26,27,27,27-hexafluoroch-olecalciferol and derivatives thereof
DE3262122D1 (en) Quinoline derivatives
GB2089348B (en) Benzopyran and benzothiapyran derivatives
GB2108109B (en) Carbostyril derivatives
IL64774A (en) Hexahydro-trans and tetrahydropyridoindole derivatives
GB2070588B (en) Carbostyril derivatives
PH16940A (en) Substituted phenoxy-aminopropanol derivatives and medicaments thereof
DE3266355D1 (en) Octahydrotetracyanoquinodimethane and derivatives thereof
DE3162888D1 (en) Cyclic acylaminoperfluoroalkanesulfonanilides and derivatives thereof
GB2124628B (en) 6-oxo-tetrahydropyran derivatives and cyanomethyl-azetidinones
JPS56110651A (en) Branched amines and derivatives thereof
JPS5732266A (en) Pyridylmethyl-benzamide derivative and manufacture
GB2090829B (en) 16-amino-pgf2 and derivatives
JPS5781481A (en) Theonyl-thio-propionyl-glycine derivative and manufacture
DE3162812D1 (en) Acyclicacylaminoperfluoroalkanesulfonanilides and derivatives thereof
EG14215A (en) Substituted-4-alkylthioalkanesulfonanilides and derivatives thereof
EG14831A (en) 4-phenylthioalkanesulfonanilides and derivatives thereof
AU545825B2 (en) Biphenylmethanols and derivatives thereof
IL72957A0 (en) 9-oximino-1-hydroxyhexahydrobenzo(c)quinoline derivatives
DE3169834D1 (en) N,n-diacylaminoperfluoroalkanesulfonanilides and derivatives thereof
IE802256L (en) Quinolines
IE802488L (en) Quinoline derivatives